Allergen Research raises $17mm through Series A; advances peanut allergy immunotherapy
Allergen Research Corp. (developing therapies to protect children with food allergies from accidental exposure) raised $17mm through its Series A round. Longitude Capital led the round, and joins Allergen’s board. The non-profit awareness group Food Allergy Research & Education (FARE), which helped found the company in 2011, also contributed.
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com